JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Tax-Exempt Bond Index Fund
VTEB
|
+$2.54B |
| 2 |
Amazon
AMZN
|
+$1.38B |
| 3 |
Vanguard Short-Term Corporate Bond ETF
VCSH
|
+$827M |
| 4 |
Public Service Enterprise Group
PEG
|
+$725M |
| 5 |
Union Pacific
UNP
|
+$721M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.49B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.03B |
| 3 |
McDonald's
MCD
|
+$1.01B |
| 4 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$871M |
| 5 |
Exelon
EXC
|
+$709M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.19% |
| 2 | Technology | 14.28% |
| 3 | Healthcare | 12.84% |
| 4 | Financials | 10.61% |
| 5 | Consumer Discretionary | 7.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
701
Dick's Sporting Goods
DKS
$13.4B
| $122M | 0.02% |
1,013,350
-339,499
| -25% | -$38.2M |
2013 Q2
38 quarters
|
|
702
RBC Bearings
RBC
$16.3B
| $122M | 0.02% |
581,646
-35,881
| -6% | -$8.2M |
2013 Q2
38 quarters
|
|
703
Apollo Global Management
APO
$67.3B
| $122M | 0.02% |
1,908,454
+69,060
| +4% | +$4.1M |
2013 Q2
38 quarters
|
|
704
iShares Russell 1000 ETF
IWB
$49.1B
| $122M | 0.02% |
577,688
+278,636
| +93% | +$59M |
2013 Q2
38 quarters
|
|
705
iShares MSCI USA Min Vol Factor ETF
USMV
$23.4B
| $122M | 0.02% |
1,685,247
+1,396,259
| +483% | +$99.4M |
2013 Q2
38 quarters
|
|
706
iShares 0-1 Year Treasury Bond ETF
SHV
$21.4B
| $121M | 0.02% |
1,101,857
-272,871
| -20% | -$30M |
2013 Q2
38 quarters
|
|
707
Expeditors International
EXPD
$25B
| $121M | 0.02% |
1,161,387
-65,986
| -5% | -$6.8M |
2013 Q2
38 quarters
|
|
708
FirstEnergy
FE
$25.1B
| $120M | 0.02% |
2,872,917
-2,412,165
| -46% | -$94.3M |
2013 Q2
38 quarters
|
|
709
iShares Russell 2000 Value ETF
IWN
$14B
| $120M | 0.02% |
863,984
-356,189
| -29% | -$50.3M |
2013 Q2
38 quarters
|
|
710
ICU Medical
ICUI
$3.99B
| $119M | 0.02% |
754,421
+8,256
| +1% | +$1.26M |
2013 Q2
38 quarters
|
|
711
East-West Bancorp
EWBC
$17.3B
| $118M | 0.02% |
1,789,495
-71,150
| -4% | -$4.87M |
2013 Q2
38 quarters
|
|
712
Clorox
CLX
$9.72B
| $118M | 0.02% |
837,912
+29,062
| +4% | +$4.12M |
2013 Q2
38 quarters
|
|
713
Shell
SHEL
$274B
| $117M | 0.02% |
2,062,953
-318,660
| -13% | -$17.6M |
2022 Q1
3 quarters
|
|
714
Ciena
CIEN
$55.5B
| $117M | 0.02% |
2,300,907
+780,761
| +51% | +$35.3M |
2013 Q2
38 quarters
|
|
715
Outset Medical
OM
$74.4M
| $117M | 0.02% |
301,097
-35,233
| -10% | -$9.94M |
2020 Q3
9 quarters
|
|
716
Alliant Energy
LNT
$16.7B
| $116M | 0.02% |
2,102,882
-42,237
| -2% | -$2.26M |
2013 Q2
38 quarters
|
|
|
EXE
717
Expand Energy Corp
EXE
$19.8B
| $116M | 0.02% |
1,228,968
+546,450
| +80% | +$54.1M |
2021 Q1
7 quarters
|
|
718
Magna International
MGA
$17.3B
| $116M | 0.02% |
2,062,278
-70,848
| -3% | -$3.98M |
2013 Q2
38 quarters
|
|
719
PUT
iShares MSCI Australia ETF
EWA
$1.21B
| $116M | 0.02% |
4,142,000
-7,059,600
| -63% | -$153M |
2013 Q2
38 quarters
|
|
720
Lamar Advertising Co
LAMR
$14.6B
| $116M | 0.02% |
1,227,046
+47,696
| +4% | +$4.41M |
2013 Q2
38 quarters
|
|
721
iShares US Aerospace & Defense ETF
ITA
$12.2B
| $115M | 0.02% |
1,031,678
+33,650
| +3% | +$3.58M |
2013 Q3
37 quarters
|
|
722
West Pharmaceutical
WST
$25.7B
| $115M | 0.02% |
490,245
+268,770
| +121% | +$63.7M |
2013 Q2
38 quarters
|
|
723
Arrowhead Research
ARWR
$9.07B
| $114M | 0.02% |
2,820,822
-71,699
| -2% | -$2.38M |
2018 Q2
18 quarters
|
|
724
Pembina Pipeline
PBA
$26.7B
| $114M | 0.02% |
3,367,855
+104,647
| +3% | +$3.51M |
2013 Q2
38 quarters
|
|
725
NorthWestern Energy
NWE
$4.26B
| $114M | 0.02% |
1,916,780
+6,393
| +0.3% | +$349K |
2013 Q2
38 quarters
|
|
Similar funds
JP Morgan Chase's Q4 2022 Portfolio in Review
As of Q4 2022, JP Morgan Chase held 7,423 positions worth $759B, up 8.9% from $696B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
JP Morgan Chase's Q4 2022 filing shows 754 new, 2,939 increased, 2,285 reduced and 593 closed positions. Its largest new stake was Invesco S&P Emerging Markets Low Volatility ETF: 2,344,997 shares worth $54M. The largest sale was Invesco QQQ Trust, an estimated $1.49B.
By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, down from 28% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q4 2022 buy was Invesco S&P Emerging Markets Low Volatility ETF: 2,344,997 shares worth $54M.
- JP Morgan Chase added most to Vanguard Tax-Exempt Bond Index Fund in Q4 2022, an estimated $2.54B increase.
- JP Morgan Chase's biggest Q4 2022 reduction was Invesco QQQ Trust, cutting an estimated $1.49B.
- JP Morgan Chase fully exited Duke Realty Corp. in Q4 2022, selling an estimated $424M.
- JP Morgan Chase's ten largest holdings make up 16% of its $759B portfolio in Q4 2022.
- JP Morgan Chase opened 754 new positions and closed 593 in Q4 2022.
- JP Morgan Chase's portfolio value rose 8.9% quarter-over-quarter to $759B.
Based on JP Morgan Chase's 13F filing for Q4 2022, filed 13 Feb 2023.